1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (6429)
  2. Meeting Abstract (3246)
  3. Editorial (116)
  4. Review (93)
  5. Research Letter (80)
  6. Correspondence (77)
  7. Conference Paper (54)
  8. Miscellaneous (52)
  9. Book Section (43)
  10. Guidelines (13)
  11. Book Whole (5)
Groups
  1. Epidemiology and Biostatistics (10208)
  2. Biostatistics Service (6565)
  3. Department of Medicine (4908)
  4. Population Sciences Research Program (4867)
  5. Surgery (3680)
  6. Survivorship Research (3598)

More Groups

People
  1. Mithat Gonen (1028)
  2. Andrew Vickers (880)
  3. Sean Devlin (601)
  4. Katherine Panageas (512)
  5. Sujata Patil (511)
  6. Nikolaus Schultz (486)

More People

Years
  1. 2025 (210)
  2. 2024 (622)
  3. 2023 (692)
  4. 2022 (732)
  5. 2021 (610)
  6. 2020 (625)

More Years

Publications
  1. Journal of Clinical Oncology (1374)
  2. Blood (534)
  3. Annals of Surgical Oncology (462)
  4. Cancer Research (274)
  5. International Journal of Radiation Oncology, Biology, Physics (258)
  6. Clinical Cancer Research (250)

More Publications

Publishers
  1. American Society of Clinical Oncology (1487)
  2. Elsevier Inc. (1206)
  3. Springer (925)
  4. American Association for Cancer Research (761)
  5. Elsevier Science, Inc. (685)
  6. American Society of Hematology (601)

More Publishers

Results (10208)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cancer survival in the context of growing hospital participation in Medicare ACOs
    Meeting Abstract

    Schleicher, S. M.; Lavery, J. A.; Barrow, B. E.; Rubin, D. M.; Radzyner, M. H.; Duck, E.; Bach, P.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Neurologic immune related adverse events (irAEs) in patients treated with immune checkpoint blockade
    Meeting Abstract

    Santomasso, B.; Haggiagi, A.; Malani, R.; Maher, C. A.; Holder, J. N.; Shames, Y.; Wilcox, J.; Flynn, J.; Briggs, S.; Panageas, K.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Using patient-reported outcomes measures to tailor care for complex cancer survivors: A feasibility study of HN-STAR
    Meeting Abstract

    Salz, T.; Salner, A. L.; Raghunathan, N. J.; McCabe, M. S.; Dornelas, E.; Finitsis, D.; Corcoran, S.; Fortier, E.; Weber, R.; Tin, A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Trends in chronic opioid therapy among cancer survivors
    Meeting Abstract

    Salz, T.; Lavery, J. A.; Lipitz Snyderman, A. N.; Boudreau, D.; Moryl, N.; Gillespie, E. F.; Korenstein, D.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Outcomes of advanced pulmonary large cell neuroendocrine carcinoma stratified by RB1 loss, SLFN11 expression, and tumor mutational burden
    Meeting Abstract

    Sabari, J. K.; Julian, R. A.; Ni, A.; Halpenny, D.; Hellmann, M. D.; Drilon, A. E.; Li, B. T.; Poirier, J. T.; Rudin, C. M.; Rekhtman, N.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • RET-rearranged lung cancers: Immunophenotype and response to immunotherapy
    Meeting Abstract

    Sabari, J. K.; Offin, M. D.; Wu, S. L.; Ni, A.; Halpenny, D.; Montecalvo, J.; Liu, D.; Pak, T. K.; Arbour, K. C.; Lai, W. C. V.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Malignant wounds associated with cancer: Delay in treatment, impairment in quality of life and associated psychosocial and financial burden
    Meeting Abstract

    Rosenbaum, B. E.; Dusza, S. W.; Goldfarb, S. B.; Barker, C. A.; Markova, A.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Clinical and molecular features predicting long-term response (LTR) to anti-PD-(L)1 based therapy in patients with NSCLC
    Meeting Abstract

    Rizvi, H.; Plodkowski, A. J.; Tenet, M.; Halpenny, D.; Long, N.; Sauter, J. L.; Sanchez-Vega, F.; Chatila, W. K.; Schultz, N.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase 1 study to evaluate safety and efficacy of nivolumab (nivo) + ipilimumab (ipi) + external beam radiotherapy (RT) in patients with metastatic melanoma
    Meeting Abstract

    Postow, M. A.; Knox, S. J.; Goldman, D.; Panageas, K.; Halpenny, D.; McCabe, D.; Macri, M. J.; Schwarzenberger, P.; Ricciardi, T.; Ryan, A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Tumor mutation burden and efficacy of targeted therapy in patients with EGFR mutant lung cancers
    Meeting Abstract

    Offin, M. D.; Rizvi, H.; Tenet, M.; Ni, A.; Sanchez Vega, F.; Kris, M. G.; Rudin, C. M.; Riely, G. J.; Yu, H. A.; Hellmann, M. D.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save